The Private Sector Advisory Facility Working Group recommends a practical way for donors and technical agencies to support successful public-private interactions to strenghthen health systems in developing countries.
In a pathbreaking follow-up to the 2008 report Girls Count, Miriam Temin and CGD vice president Ruth Levine shed light on the reality of girls’ health worldwide and its enormous on the wellbeing and productivity of girls, their families, and their nations. Start with a Girl: A New Agenda for Global Health highlights successful efforts to break the cycle of ill health and proposes a comprehensive, practical health agenda that starts with adolescent girls.
Countering Drug Resistance in the Developing World: An Assessment of Incentives across the Value Chain and Recommendations for Policy Interventions - Working Paper 183
In this working paper, commissioned as part of CGD's Drug Resistance Working Group, Prashant Yadav analyzes how changes in supply-chain business practices could help fix the misaligned incentives that hinder worldwide access to high-quality medical goods.
Few people doubt that gender inequality influences the spread of HIV/AIDS, yet public health efforts tend to focus on changing individual behavior rather than addressing structural factors—social, economic, physical and political—that influence the spread and effects of HIV and AIDS. This brief shows how three of the biggest donors to global HIV/AIDS programs can go beyond their stated commitments to address gender inequality and more effectively combat HIV and AIDS.
Before a 2006 UN Special Session proclaimed there should be universal access to antiretrovirals (ARV), the life-saving drugs were far too expensive for most people with AIDS. In a new CGD working paper, Ethan Kapstein and Josh Busby examine how activists transformed ARVs from expensive private goods into so-called merit goods—products that society agrees should be accessible to all. In a related blog post they discuss the implications of their analysis for AIDS and other global challenges.
READ THE BLOG | GO STRAIGHT TO THE WORKING PAPER
Undernutrition kills more than three million mothers and children annually, and millions more children suffer irreversible, long-term damage to their bodies and minds. Yet nutrition is too often a low priority for rich-world donors and even for governments in the most affected countries. A new CGD essay by Ruth Levine and Danielle Kuczynski shows why and offers two practical suggestions for improvement.
READ THE ESSAY
Gender inequality drives the HIV epidemic, increasing the burden on women and girls and undermining the global response to the disease. A new HIV/AIDS Monitor report finds that despite well-meaning language and admirable broad goals, three of the biggest HIV/AIDS funders have yet to translate their concern for women and girls into systematic, effective programming. The report shows how to make that happen.
Donor spending on global health has surged, yet for many poor people in developing countries even basic prevention and treatment remain elusive. CGD’s newest book, Performance Incentives for Global Health: Potential and Pitfalls, shows how modest payments in cash or kind can get more health from health care spending. Informed by case studies and the Working Group on Performance-Based Incentives, co-authors Rena Eichler and CGD vice president Ruth Levine tell how to design and implement effective incentive programs—and what to avoid.
This dataset compiles selected global variables on AIDS and its treatment and prevention. The data are in the format developed by the Stata statistical software corporation and are intended for use with Over and McCarthy's AIDSCost package for the purpose of projecting the future budgetary cost of scaling up AIDS treatment.
CGD senior fellow Mead Over and Owen McCarthy offer a users' manual and Stata software to help students and instructors of public health, development economics, or health economics to project the future budgetary cost of AIDS treatment in poor countries and to explore the many factors affecting the calculation.
CGD policy analyst Lindsay Morgan summarizes the global health agendas various organizations have recommended to the Obama administration. She finds that the calls for a smarter, more harmonized, results-based global health agenda are clear.
Rena Eichler and Ruth Levine summarize the findings of their book, Performance Incentives for Global Health: Potential and Pitfalls. Through numerous case studies, they show that carefully designed and implemented performance-based incentive programs can improve developing country health care in many areas and strengthen overall health systems.
This report by the UNAIDS Leadership Transition Working Group argues that the new executive director of the Joint United Nations Programme on HIV/AIDS should focus on a few essential tasks: promoting evidence-based prevention and treatment strategies, ensuring that UN agencies adequately support countries severely affected by HIV, and pressing rich-country governments to live up to their pledges to help poor countries respond to the epidemic.
AIDS Treatment in South Asia: Equity and Efficiency Arguments for Shouldering the Fiscal Burden When Prevalence Rates Are Low - Working Paper 161
Senior fellow Mead Over estimates the effect of AIDS on poverty in South Asia and analyzes public policy options to help the region’s predominantly private health care systems meet the challenge of treating AIDS. He finds that South Asian governments should play a larger role in AIDS treatment than in other aspects of health care, in the interest of both efficiency and equity.
Since 2004, the Center for Global Development has been collecting success stories in global health – remarkable cases in which large-scale efforts to improve health in developing countries have succeeded – and releasing them in the book Millions Saved: Case Studies in Global Health (now printed in two editions, with a third edition expected in 2015).
The debate on user fees in health and education has been contentious, but until recently much of the evidence has been anecdotal. Does charging poor people for health and education services improve or impede access? CGD non-resident fellow Michael Kremer and co-author Alaka Holla survey the evidence from recent randomized evaluations across a variety of settings to find out. The verdict: higher prices decrease access.
Read the working paper